How long after ingestion can ivermectin be detected in blood, urine, or hair samples?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Plasma/whole-blood ivermectin concentrations fall into the low-ng/mL range within days after a single oral dose; published HPLC and LC‑MS/MS methods measured plasma for at least 56–72 hours post-dose and validated assays down to ~1 ng/mL [1] [2]. Ivermectin is highly lipophilic, >90% protein‑bound, concentrates in tissues (fat, skin) and is excreted mainly in feces over ~12 days with <1% recovered in urine, which limits urine detection [3] [2] [4] [5].
1. How long blood (plasma/whole blood) can show ivermectin — short answer and why
Studies using HPLC and LC‑MS/MS demonstrate measurable ivermectin in plasma/whole blood for at least 56–72 hours after a single oral dose; elimination half‑lives reported around ~12–13 hours in early HPLC work (so concentrations drop substantially over days) and modern LC‑MS/MS methods quantify in the 0.97–384 ng/mL range for validation [1] [2]. Tissue distribution and high protein binding (>90%) mean blood levels are relatively low while tissue reservoirs persist [2] [4].
2. Urine detection is limited — the evidence
Multiple reviews and analytical studies report that ivermectin and most metabolites are excreted in feces, with only about 1% or less recovered in urine; several authors were unable to detect parent drug or metabolites in urine, and older HPLC assays found no unchanged or conjugated ivermectin in urine after single doses [3] [1] [5]. Analytical efforts for urine detection exist (electrochemical sensors, voltammetry) but selectivity and sensitivity issues have been reported [6].
3. Hair analysis — possible in principle but not well documented in humans
Hair testing can capture drug exposure over weeks to months because hair grows ~1 cm/month, but available sources do not provide human ivermectin hair‑detection studies or validated hair PK data; veterinary topical avermectin residues on coat/hair were detectable for weeks in animals, suggesting hair residue is plausible but human data are not reported in current sources [7] [8]. Available sources do not mention validated human hair‑testing timelines for ivermectin.
4. Tissue reservoirs and extended pharmacodynamic effects
Ivermectin is lipophilic, distributes into fat, skin and other tissues and shows persistence in those compartments; this explains observations such as mosquito‑lethal effects on blood taken from treated people lasting beyond expected plasma half‑life (effects observed up to ~28 days in some vector studies), even though plasma elimination is faster [9] [2]. That discrepancy reflects tissue depots and active metabolites rather than long high plasma levels [9].
5. What analytical methods determine detection windows
High‑performance liquid chromatography with fluorometric detection detected plasma concentrations up to ~56–72 hours after single oral doses with lower limits ~1 ng/mL [1]. More sensitive LC‑MS/MS methods have been validated in plasma/whole blood down to sub‑ng/mL–low ng/mL ranges (validation range example 0.97–384 ng/mL) enabling detection for as long as measurable above assay limits [2]. Urine and electrochemical approaches have been pursued but face selectivity or low recovery challenges [6] [1].
6. Practical interpretation and limitations for testing
Expect blood/plasma detection for a few days after standard oral dosing when using sensitive LC‑MS/MS or optimized HPLC assays; detectability beyond that depends on assay sensitivity and whether low‑ng/mL or sub‑ng/mL levels are clinically significant [1] [2]. Urine is a poor matrix for detecting parent ivermectin because <1% is excreted there and multiple studies failed to find unchanged drug in urine [5] [1]. Hair could, in theory, provide months‑long windows, but human validation is not found in current reporting [8] [7].
7. Competing perspectives and research gaps
Analytical chemistry papers (HPLC, LC‑MS/MS, electrochemical sensors) focus on technical detection limits and matrices [1] [6] [2]. Entomology/pharmacodynamic research notes mosquito‑lethality persisting longer than plasma PK predicts, implying metabolites or tissue release may matter [9]. Sources disagree implicitly on the utility of urine: some methods attempt urine detection but classical reviews and assays report little to none in urine (p1_s3 vs [1]; p1_s5). Important gap: human hair‑testing for ivermectin lacks published, validated timelines in the provided literature (available sources do not mention validated human hair detection for ivermectin).
8. Bottom line for clinicians, forensic toxicologists and the public
For routine detection after a single oral dose, rely on plasma/whole‑blood LC‑MS/MS or sensitive HPLC to detect ivermectin for a few days (measurable to ~56–72 hours in classic studies); urine testing is unlikely to detect parent drug because <1% is excreted there; hair testing remains speculative based on current reporting and requires validated human methods [1] [2] [5] [8].